San Francisco, CA, United States of America

Suganya Selvarajah

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Prosetta Antiviral, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suganya Selvarajah. Retrieved from https://idiyas.com/inventor/suganya-selvarajah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suganya Selvarajah: Innovator in Antiviral Compounds

Introduction

Suganya Selvarajah is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of antiviral research. Her work focuses on developing compounds that can effectively treat viral infections.

Latest Patents

Suganya holds a patent for N-methyl pyrazoles. This invention provides, among other things, compounds useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus or treating a disease. Her innovative approach has the potential to impact the pharmaceutical industry significantly.

Career Highlights

Suganya is currently employed at Prosetta Antiviral, Inc. Her role involves extensive research and development in antiviral therapies. She has demonstrated a strong commitment to advancing medical science through her inventions.

Collaborations

Suganya collaborates with her coworker, Kumar Paulvannan. Together, they work on innovative solutions to combat viral infections.

Conclusion

Suganya Selvarajah is a dedicated inventor whose work in antiviral compounds showcases her commitment to improving healthcare. Her contributions are paving the way for new treatments in the fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…